Skip to main content

Navigation group

Type at least 3 characters
16,746 articles

Articles

Study Protocol

Published on 18 Jul 2024

Cladribine effects on patient-reported outcomes and their clinical and biometric correlates in highly active relapsing multiple sclerosis at first switch: the observational, multicenter, prospective, phase IV CLADFIT-MS study

in Multiple Sclerosis and Neuroimmunology

  • Giovanna Borriello
  • Clara Grazia Chisari
  • Davide Maimone
  • Massimiliano Mirabella
  • Damiano Paolicelli
  • Francesco Assogna
  • Sandro Caradonna
  • Francesco Patti
Cladribine effects on patient-reported outcomes and their clinical and biometric correlates in highly active relapsing multiple sclerosis at first switch: the observational, multicenter, prospective, phase IV CLADFIT-MS study
Frontiers in Neurology
doi 10.3389/fneur.2024.1422078
  • 1,332 views